Viral Related Malignancies

  • Marc E. Grossman
  • Lindy P. Fox
  • Carrie Kovarik
  • Misha Rosenbach


Between 15% and 20% of all global malignancies are attributable to an infectious agent.1 These range from bacterial infections such as Helicobacter pylori (associated with stomach carcinoma and gastric lymphoma), to parasitic infections such as Opisthorchis viverrini (a liver fluke associated with cholangiocarcinoma) and Schistosoma haematobium (a blood fluke associated with bladder carcinoma), to viral infections such as the hepatitis viruses (associated with hepatocellular carcinoma), herpes viruses (associated with a range of cancers including various lymphomas and Kaposi’s sarcoma), and human papillomaviruses (associated with cervical and skin cancers).2 This chapter will focus on viral-associated malignancies with cutaneous findings that occur in immunocompromised hosts.


Human Immunodeficiency Virus Merkel Cell Carcinoma Verrucous Carcinoma Schistosoma Haematobium Human Immunodeficiency Virus Coinfection 


  1. 1.
    McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta. 2008;1782(3):127–50.CrossRefPubMedGoogle Scholar
  2. 2.
    Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030–44.CrossRefPubMedGoogle Scholar

Human Papillomavirus

  1. 3.
    Tedeschi SK, Savani BN, Jagasia M, et al. Time to consider HPV vaccination after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2010;16:1033–6.CrossRefPubMedGoogle Scholar
  2. 4.
    Espana A, Redondo P, Fernandez AL, et al. Skin cancer in heart transplant recipients. J Am Acad Dermatol. 1995;32:458–65.CrossRefPubMedGoogle Scholar
  3. 5.
    Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst. 1996;88:802–11.CrossRefPubMedGoogle Scholar
  4. 6.
    Berkhout RJ, Tieben LM, Smits HL, et al. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol. 1995;33:690–5.PubMedGoogle Scholar
  5. 7.
    Glover MT, Deeks JJ, Raftery MJ, Cunningham J, Leigh IM. Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet. 1997;349:398.CrossRefPubMedGoogle Scholar
  6. 8.
    Vidulich KA, Rady PL, He Q, Tyring S, Duvic M. Detection of high-risk human papillomaviruses in verrucae of patients with mycosis fungoides and Sezary syndrome: a case series. Int J Dermatol. 2009;48:598–602.CrossRefPubMedGoogle Scholar
  7. 9.
    Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancer after bone marrow transplantation. New Engl J Med. 1997;336:897–904.CrossRefPubMedGoogle Scholar
  8. 10.
    Handisurya A, Rieger A, Bankier A, et al. Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy. Br J Dermatol. 2007;157:788–94.CrossRefPubMedGoogle Scholar
  9. 11.
    Cohen LM, Tyring SK, Rady P, Callen JP. Human papillomavirus type 11 in multiple squamous cell carcinomas in a patient with subacute cutaneous lupus erythematosus. J Am Acad Dermatol. 1992;26:840–5.CrossRefPubMedGoogle Scholar
  10. 12.
    Schwartz RA. Verrucous carcinoma of the skin and mucosa. J Am Acad Dermatol. 1995;32:1–21.CrossRefPubMedGoogle Scholar
  11. 13.
    Lubbe J, Kormann A, Adams V, et al. HPV-11 and HPV-16-associated oral verrucous carcinoma. Dermatology. 1996;192:217–21.CrossRefPubMedGoogle Scholar
  12. 14.
    Dubina M, Goldenberg G. Viral-associated nonmelanoma skin ­cancers: a review. Am J Dermatopathol. 2009;31:561–73.CrossRefPubMedGoogle Scholar
  13. 15.
    Handisurya A, Rieger A, Bago-Horvath Z, et al. Rapid progression of an anal Buschke-Lowenstein tumour into a metastasizing squamous cell carcinoma in an HIV-infected patient. Sex Transm Infect. 2009;85:261–3.CrossRefPubMedGoogle Scholar
  14. 16.
    Massad LS, Ahuja J, Bitterman P. Verrucous carcinoma of the vulva in a patient infected with the human immunodeficiency virus. Gynecol Oncol. 1999;73:315–8.CrossRefPubMedGoogle Scholar
  15. 17.
    Chung SD, Huang KH, Lai YH, et al. Synchronous advanced scrotal verrucous carcinoma with peripheral T-cell lymphoma. Urology. 2007;69:184.e5–7.CrossRefGoogle Scholar
  16. 18.
    Parsons AC, Sheehan DJ, Sangueza OP. Synchronous verrucous carcinoma and cutaneous T-cell lymphoma. J Am Acad Dermatol. 2008;58:S124–5.CrossRefPubMedGoogle Scholar
  17. 19.
    Gormely RH, Kovarik CL. Dermatologic manifestations of HPV in HIV-infected individuals. Curr HIV/AIDS Rep. 2009;6:130–8.CrossRefGoogle Scholar
  18. 20.
    Rogers HD, MacGregor JL, Nord KM, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2009;60:315–20.CrossRefPubMedGoogle Scholar
  19. 21.
    Holmes C, Chong AH, Tabrizi SN, Downes N, Nindl I. Epidermodysplasia verruciformis-like syndrome in association with systemic lupus erythematosus. Australas J Dermatol. 2009;50:44–7.CrossRefPubMedGoogle Scholar
  20. 22.
    Kunishige JH, Hymes SR, Madkan V, et al. Epidermodysplasia verruciformis in the setting of graft-versus–host disease. J Am Acad Dermaol. 2007;57:S78–80.CrossRefGoogle Scholar
  21. 23.
    Oliveira WR, Ferreira GN, Rady PL, Festa C, Tyring SK. Epidermodysplasia verruciformis associated with myelodysplastic syndrome: an intriguing association. J Cutan Med Surg. 2009;13:317–20.PubMedGoogle Scholar

Epstein-Barr Virus

  1. 24.
    Ferreri AJM, Ernberg I, Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med. 2009;265:421–38.CrossRefPubMedGoogle Scholar
  2. 25.
    Tao Q, Young LS, Woodman CBJ, Murray PG. Epstein-Barr virus (EBV) and its associated human cancers – genetics, epigenetics, pathobiology and novel therapeutics. Front Biosci. 2006;11:2672–713.CrossRefPubMedGoogle Scholar
  3. 26.
    Aoki R, Mitsui H, Harada K, et al. A case of lymphoepithelioma-like carcinoma of the skin associated with Epstein-Barr virus infection. J Am Acad Dermatol. 2008;62:681–4.CrossRefGoogle Scholar
  4. 27.
    Salama S, Todd S, Cina DP, Margetts P. Cutaneous presentation of post-renal transplant lymphoproliferative disorder: a series of four cases. J Cutan Pathol. 2010;37:641–53.CrossRefPubMedGoogle Scholar
  5. 28.
    Capaldi L, Robinson-Bostom L, Kerr P, Gohh R. Localized cutaneous posttransplant Epstein-Barr virus-associated lymphoproliferative disorder. J Am Acad Dermatol. 2004;51:778–80.CrossRefPubMedGoogle Scholar
  6. 29.
    Schumann KW, Oriba HA, Bergfeld WF, et al. Cutaneous presentation of posttransplant lymphoproliferative disorder. J Am Acad Dermatol. 2000;42:923–6.CrossRefPubMedGoogle Scholar
  7. 30.
    Chai C, White WL, Shea CR, Prieto VG. Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Pathol. 1999;26:242–7.CrossRefPubMedGoogle Scholar
  8. 31.
    Snavely NR, Sonabend M, Rosen T. Posttransplant Epstein-Barr virus related lymphoproliferative disorder with a primary cutaneous presentation. Dermatol Online J. 2007;13:7.PubMedGoogle Scholar
  9. 32.
    Hernandez C, Cetner AS, Wiley EL. Cutaneous presentation of ­plasmablastic post-transplant lymphoproliferative disorder in a 14-month-old. Pediatr Dermatol. 2009;26:713–6.CrossRefPubMedGoogle Scholar
  10. 33.
    Chiu LS, Choi PCL, Luk NM, Chang M, Tang WYM. Spontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart transplant recipient. Clin Exp Dermatol. 2009;34:e21–4.CrossRefPubMedGoogle Scholar
  11. 34.
    Lucioni M, Ippoliti G, Campana C, et al. EMV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. Am J Transplant. 2004;4:1915–20.CrossRefPubMedGoogle Scholar
  12. 35.
    Coyne JD, Banerjee SS, Bromley M, et al. Post-transplant T-cell lymphoproliferative disorder/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature. Histopathology. 2004;44:387–93.CrossRefPubMedGoogle Scholar
  13. 36.
    Harabuchi Y, Takahara M, Kishibe K, et al. Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features. Int J Clin Oncol. 2009;14:181–90.CrossRefPubMedGoogle Scholar
  14. 37.
    Cobo F, Talavera P, Busguier H, Concha A. CNK/T-cell brain lymphoma associated with Epstein-Barr virus in a patient with AIDS. Neuropathology. 2007;27:396–402.CrossRefPubMedGoogle Scholar
  15. 38.
    Kim JS, Kim SJ, Kim JS, et al. Report of AIDS-related lymphoma in South Korea. Jpn J Clin Oncol. 2008;38:134–9.CrossRefPubMedGoogle Scholar
  16. 39.
    Oh SC, Choi CW, Kim BS, et al. NK/T-cell lymphoma associated with Epstein-Barr virus in a patient infected with human immunodeficiency virus: an autopsy case. Int J Hematol. 2004;79:480–3.CrossRefPubMedGoogle Scholar
  17. 40.
    Momose A, Mizuno H, Kajihara S, et al. EBV-associated nasal-type NK/T-cell lymphoma of the nasal cavity/paranasal sinus in a renal allograft recipient. Nephrol Dial Transplant. 2006;21:1413–6.CrossRefPubMedGoogle Scholar
  18. 41.
    Stadlmann S, Fend F, Moser P, et al. Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of the literature. Human Pathol. 2001;32:1264–8.CrossRefGoogle Scholar
  19. 42.
    Jia H, Sun T. Extranodal NK/T-cell lymphoma mimicking cellulitis. Leuk Lymphoma. 2004;45:1467–70.CrossRefPubMedGoogle Scholar

Human Herpes Virus 8 (HHV8)

  1. 43.
    Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science. 1994;266:1865–9.CrossRefPubMedGoogle Scholar
  2. 44.
    Wen KW, Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis. Cancer Lett. 2010;28:140–50.CrossRefGoogle Scholar


  1. 45.
    Jiang M, Abend JR, Johnson SF, Imperiale MJ. The role of polyomaviruses in human disease. Virology. 2009;384:266–73.CrossRefPubMedGoogle Scholar
  2. 46.
    Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319:1096–100.CrossRefPubMedGoogle Scholar
  3. 47.
    Rockville Merkel Cell Carcinoma Group. Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol. 2009;27:4021–6.CrossRefGoogle Scholar
  4. 48.
    Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58:375–81.CrossRefPubMedGoogle Scholar

Human T-Cell Lymphotrophic Virus (HTLV)

  1. 49.
    Nobre V, Guedes AC, Martins ML, et al. Dermatological findings in 3 generations of a family with a high prevalence of human T cell ­lymphotropic virus type 1 infection in Brazil. Clin Inf Dis. 2006;43:1257–63.CrossRefGoogle Scholar
  2. 50.
    Arch EL, Schaefer JT, Dahiya A. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-1. Dermatol Online J. 2008;14(12):6.PubMedGoogle Scholar
  3. 51.
    Montes M, Sanchez C, Verdonck K, et al. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis. 2009;3:1–8.CrossRefGoogle Scholar
  4. 52.
    del Giudice P, Sainte Marie D, Gérard Y, Couppié P, Pradinaud R. Is crusted (Norwegian) scabies a marker of adult T cell leukemia/lymphoma in human T lymphotropic virus type I-seropositive patients? J Infect Dis. 1997;176(4):1090–2.CrossRefPubMedGoogle Scholar

Human Immunodeficiency Virus (HIV)

  1. 53.
    Wilkins K, Turner R, Dolev JC, et al. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol. 2006;54:189–206.CrossRefPubMedGoogle Scholar
  2. 54.
    Castillo J, Dezube BJ, Pantanowitz L. Plasmablastic lymphoma in HIV: a review of 131 cases. J Clin Oncol. 2008;26:abstr 19519.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Marc E. Grossman
    • 1
  • Lindy P. Fox
    • 2
  • Carrie Kovarik
    • 3
  • Misha Rosenbach
    • 4
  1. 1.New York Presbyterian HospitalColumbia University Medical CenterNew YorkUSA
  2. 2.University of California, San FranciscoSan FranciscoUSA
  3. 3.Dermatopathology, and Infectious DiseasesUniversity of PennsylvaniaPhiladelphiaUSA
  4. 4.University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations